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Abstract
Although, increased oxidative stress and hypomethylation of long interspersed nuclear element-1 (LINE-1) associate with
bladder cancer (BCa) development, the relationship between these alterations is unknown. We evaluated the oxidative
stress and hypomethylation of the LINE-1 in 61 BCa patients and 45 normal individuals. To measure the methylation levels
and to differentiate the LINE-1 loci into hypermethylated, partially methylated and hypomethylated, peripheral blood cells,
urinary exfoliated cells and cancerous tissues were evaluated by combined bisulfite restriction analysis PCR. The urinary total
antioxidant status (TAS) and plasma protein carbonyl content were determined. The LINE-1 methylation levels and patterns,
especially hypomethylated loci, in the blood and urine cells of the BCa patients were different from the levels and patterns
in the healthy controls. The urinary TAS was decreased, whereas the plasma protein carbonyl content was increased in the
BCa patients relative to the controls. A positive correlation between the methylation of LINE-1 in the blood-derived DNA
and urinary TAS was found in both the BCa and control groups. The urinary hypomethylated LINE-1 loci and the plasma
protein carbonyl content provided the best diagnostic potential for BCa prediction. Based on post-diagnostic samples, the
combination test improved the diagnostic power to a sensitivity of 96% and a specificity of 96%. In conclusion, decreased
LINE-1 methylation is associated with increased oxidative stress both in healthy and BCa subjects across the various tissue
types, implying a dose-response association. Increases in the LINE-1 hypomethylation levels and the number of
hypomethylated loci in both the blood- and urine-derived cells and increase in the oxidative stress were found in the BCa
patients. The combination test of the urinary hypomethylated LINE-1 loci and the plasma protein carbonyl content may be
useful for BCa screening and monitoring of treatment.
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Introduction
Carcinogenesis of the urinary bladder is complex because both
genetic mutations and epigenetic alterations play important roles.
Furthermore, inflammation and oxidative stress critically contrib-
ute to development of bladder cancer (BCa) [1–3]. Various lines of
evidence report an increased oxidative stress in patients with BCa
[3–6]. Oxidative stress is a condition of the excessive production of
reactive oxygen species (ROS) and/or a reduction of antioxidants.
ROS directly damages the cellular DNA and promotes tumor
development not only through genetic mutations but also through
epigenetic alterations [7]. Common epigenetic alterations in
human cancers include global hypomethylation and regional
(site-specific CpG island promoter) hypermethylation of the tumor
suppressor genes [8,9]. Hypomethylation of the cancer genome
occurs on the repetitive sequences and retrotransposable elements
[10], which accelerates the genomic instability [10–13] and alters
gene expression [14]. The best characterized and most abundant
retrotransposon in the mammalian genome is the long interspersed
nuclear element-1 (LINE-1 or L1), and it is known that LINE-1
hypomethylation is associated with many malignancies [15,16].
In urothelial cancer, the hypomethylation of LINE-1 was first
demonstrated in urothelial cell lines and tumor tissues by Schulz
and colleagues based on experiments using methylation-sensitive
restriction enzymes (HpaII/MspI) and Southern blotting [17,18].
The LINE-1 hypomethylation corresponded well with an increase
in the LINE-1 transcripts and a decrease in gene containing LINE-
1 mRNA [14]. Later, our group employed a combined bisulfite
restriction analysis (COBRA) PCR to demonstrate LINE-1
hypomethylation in various carcinomas tissues including bladder
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37009cancer [15]. Choi et al. used bisulfite-PCR pyrosequencing and
showed an obvious hypomethylation of LINE-1 in bladder tumor
tissues relative to the adjacent normal tissues [19]. The reduction
of 5-methylcytosine levels in leukocyte DNA was shown in Spanish
patients with bladder cancer relative to the matched controls [20].
Recently, the hypomethylation of LINE-1 in peripheral blood cells
was associated with an increased risk for bladder cancer, especially
in women [21]. Among nonsmoking Chinese, similar result that
LINE-1 hypomethylation in lymphocytes was associated with
increased risk for bladder cancer was demonstrated [22]. Pre-
viously, the methylation of LINE-1 in urinary exfoliated cells and
its implication in bladder cancer has not been investigated. Even
though LINE-1 hypomethylation and increased oxidative stress
are well recognized in BCa patients, the association between these
two phenomena has not been explored.
To date, the most commonly used techniques for measuring
LINE-1 methylation level are pyrosequencing and COBRA PCR.
These two methods had have similar efficacy in the detection of
methylation levels and have limited margins of error [23]. The
pyrosequencing of LINE-1 detects a few more CpG dinucleotides,
usually three CpGs, [24] than the COBRA PCR detects (usually
two CpGs). However, the LINE-1 methylation of each locus is not
homogenous [23,25], which can influence expression and stability
of the genome in cis [16]. Consequently, the LINE-1 methylation
levels do not precisely represent the biological roles of the
epigenomic modification [16]. To improve LINE-1 methylation
evaluation, in addition to overall methylation level, we used
COBRA PCR of LINE-1 to classify the genome-wide LINE-1 loci
into four groups,
mC
mC (hypermethylated),
uC
uC (hypomethy-
lated),
mC
uC and
uC
mC (partial methylated), and calculate the
percentages of each group (Fig. 1) [26]. Of note, certain LINE-1
methylation assays have a positive methylation control base which
can be use to determine the efficacy of the bisulfite treatment.
To evaluate the association between oxidative stress and LINE-
1 hypomethylation, we determined the methylation levels of
LINE-1 in the blood and urine cells obtained from the BCa
patients and from the healthy individuals. Oxidative stress,
indicated by the urinary total antioxidant status (TAS) and plasma
protein carbonyl content, was compared between the two groups.
The association of the LINE-1 methylation levels with the
oxidative stress status was evaluated, and the usefulness of
LINE-1 hypomethylation detection in the urinary exfoliated cells
and the overall oxidative stress as markers for BCa diagnosis was
assessed.
Materials and Methods
Participants
Sixty-one patients with BCa that were admitted to the King
Chulalongkorn Memorial Hospital, Bangkok, Thailand between
2009 and 2010 were recruited for the study. All of the patients had
histological proof of a superficial transitional cell carcinoma. Any
BCa patients that presented with a muscle invasive phenotype
were excluded from this study. Age- and gender-matched healthy
individuals (n=45) were used as controls. The controls were
selected from members of the healthy elderly community at
Lumpini Park, Bangkok, where they came everyday to do exercise.
The healthy condition was confirmed by direct interview and their
annual medical check-up to ensure that there was no history of
urinary disorders and any malignancies. All subjects voluntarily
participated in the study. The study protocol was reviewed and
approved by the Ethics Committee of the Faculty of Medicine,
Chulalongkorn University, Bangkok, Thailand. Written informed
consents were obtained from all participants.
Specimen collection and DNA extraction
Heparinized blood and midstream spot morning urine (between
8:00 am and 12:00 pm) were collected from all participants. The
blood samples were centrifuged to collect the plasma and buffy
coat. The plasma samples were kept at 280uC until testing. The
buffy coat samples were immediately subjected to DNA extraction.
To isolate the urinary exfoliated cells, 50 ml of the urine samples
was centrifuged at 4,000 rpm for 20 min at 4uC. The cell pellet
was collected and stored in RNA stabilizer (QIAGEN, Germany)
at 280uC until analysis. Of the 61 BCa patients, 14 had available
cancerous tissues, which were obtained during the operation of
transurethral resection, immediately stored in RNA stabilizer and
kept at 280uC for the LINE-1 measurement. Due to low amount
of nucleated cells in urines, especially in healthy urines, DNAs
from urinary exfoliated cells were successfully extracted from 30
BCa patients and 14 healthy controls. The DNA was extracted
from peripheral blood buffy coats, urinary exfoliated cells and
cancerous tissues using the High Pure PCR Template Preparation
Kit (Roche Diagnostics, Indianapolis, USA). The incomplete
specimen collection was considered as a weakness of the study. In
BCA group, the blood, urinary exfoliated cells and cancerous
tissues were accounted for 61 (100%), 30 (49.18%) and 14
(22.95%), respectively. Fourteen BCa patients (22.95%) had all
types of specimens for analysis. In healthy control group, 45
(100%) blood and 14 (31.11%) urinary exfoliated cells samples
were analyzed. Fourteen control subjects (31.11%) had both
specimens for analysis. The power to detect the correlation
observed for an n=14 was calculated using the G*Power 3.1.3
software [27], and the output displayed the power of 0.66 (inputs:
two-tails, effect size=0.56, a=0.05, total sample size=14).
LINE-1 methylation by COBRA PCR
In brief, genomic DNAs (250 ng) derived from blood, urine and
cancerous tissue samples were treated with sodium bisulfite as
previously described [15]. The bisulfite-treated DNA was sub-
jected to 35 cycles of PCR with LINE-1-F (59-CCGT AAG
GGGTTAGGGAGTTTTT-39) and LINE-1-R (59-
RTAAAACCCTCCRAACCAAAT ATAAA-39) primers with an
annealing temperature of 50uC to generate 160 bp PCR
amplicons. The amplicons were further digested with TaqI( 2U )
(sticky end) and TasI (2 U) (sticky end) in NEB3 buffer (MBI
Fermentas, Glen Burnie, MD) at 65uC overnight. The digested
products were then electrophoresed in an 8% nondenaturing
polyacrylamide gel and subsequently stained with SYBR green.
The experiment was performed in duplicate.
The intensities of the COBRA LINE-1 fragments in the
polyacrylamide gel were quantified using a phosphoimager and
ImageQuant Software (Molecular Dynamics, GE Healthcare,
Slough, UK). As detected by COBRA, methylation status of the 2
CpG dinucleotides of LINE-1 loci was classified into four groups
as follows: (1) LINE-1 loci containing 2 unmethylated CpGs
(
uC
uC); (2) LINE-1 loci containing 2 methylated CpGs (
mC
mC); (3)
LINE-1 loci containing 59-methylated and 39-unmethylated CpGs
(
mC
uC); and (4) LINE-1 loci containing 59-unmethylated and 39-
methylated CpGs (
uC
mC). The details for band intensity
quantitation was fully described elsewhere [28]. In brief, four
bands that differed in their states of methylation, including 98 bp
(
uC
uC), 160 (
mC
uC) ,8 0(
mC ) and 62 (
uC) bp, were quantified
(Fig. 1). The intensity of each band was divided by its paired length
as followed: 160 bp/160 (A), 98 bp/94 (B), 80 bp/79 (C) and
62 bp/62 (D). The LINE-1 methylation level (overall or total) was
calculated as the percent of the methylated bands (
mC ) intensity
divided by the sum of the
mC and unmethylated bands (
uC)
intensities, (C+A)/(C+A+A+B+D)6100. The percent of
uC
uC
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B/(((C2D+B)/2)+A+D)6100. The
mC
uC (partial methylated loci)
was computed from the equation: A/(((C2D+B)/2)+A+D)6100.
The
mC
mC (hypermethylated loci) was computed from the
equation: ((C2D+B)/2)/(((C2D+B)/2)+D+A)6100. The CV of
the LINE-1 methylation levels in blood, urinary exfoliated cells
and cancerous tissues DNAs were 7.31% (range: 2.33–12.91%),
7.64% (range: 2.50–13.17%) and 8.00% (range: 3.56–10.54%),
respectively. DNA from HeLa cells was used as a control to
normalize the inter-assay methylation variation for all of the
experiments (Fig. 1F). The percent of LINE-1 methylation
detected in HeLa DNAs was 28.59%, and this value was used
for normalization between the runs. The mean of LINE-1
methylation in HeLa DNAs was 27.7462.33%, and the
between-run CV was 8.41%.
Total antioxidant status (TAS)
The 2, 2-diphenyl-1-picryl-hydrazyl (DPPH) reduction assay
was performed to determine the TAS in urine samples. Briefly,
a urine sample (20 mL) was added to of 400 mLo f1 0 m M
phosphate buffered saline (PBS, pH 7.4) and 400 mL of freshly
prepared 0.1 mM DPPH in methanol. The reaction tubes were
incubated at room temperature for 20 min in the dark. The
optical density (OD) at 520 nm was measured. The antioxidant
capacity of the sample was calculated based on the % inhibition of
DPPH radicals using the following equation: % inhibition=(OD-
blank2ODsample/ODblank)6100. L-ascorbic acid (vitamin C) was
used at concentrations of 0.25, 0.5 and 1 mM to generate
a standard curve (% inhibition vs. concentration). The TAS value
of the urine sample was expressed as the vitamin C equivalent
antioxidant capacity (VCEAC mM). All experiments were done in
Figure 1. The methylation patterns of LINE-1 detected by COBRA PCR. A: The detecting 59 UTR of the LINE-1 sequence contains two CpG
dinucleotide loci, and the PCR amplicon size of LINE-1 is 160 bp. B: There are 4 possible methylation patterns of the LINE-1 sequence (one cell
contains two alleles). The solid stars represent methylated cytosines and the hollow stars represent unmethylated cytosines. C: COBRA LINE-1
separated the detecting region into four products:
mC
mC,
uC
uC,
mC
uC and
uC
mC. D: After the bisulfite treatment, the unmethylatated cytosine residues
are converted to uracil, but the methylated cytosine residues are unaltered. This leads to retention or loss of CpG containing restriction enzyme sites,
respectively. E: The PCR products are digested with TaqI (recognition sequence: TCGA) and TasI (recognition sequence: AATT) restriction enzymes. A
TaqI positive digest yields two 80-bp DNA fragments, while a TasI positive digest yields a 62- and a 98-bp fragment. F: Representative gel image for
COBRA LINE-1 assay. Lanes 1–2: DNAs from BCa patients, Lanes 3–5: DNAs from healthy controls, Lane 6: DNA from HeLa cells as positive control and
normalizing sample, Lane 7: negative (N) control, Lane 8: 25 bp markers.
doi:10.1371/journal.pone.0037009.g001
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(range: 1.02–14.59%).
Protein carbonyl determination
The protein carbonyl content was used as an indicator of
protein oxidation by ROS in plasma. A plasma sample was diluted
(1:20) with PBS (10 mM, pH 7.4) and then centrifuged at
10,000 rpm for 10 min. The plasma supernatant (250 mL) was
added to 1 mL of 10 mM 2,4-dinitrophenylhydrazine (DNPH) in
2N HCl. For a reagent blank control, 1 mL of 2N HCl was added
to 250 mL of the plasma supernatant. The mixtures were
incubated at room temperature in the dark for 45 min and were
vortexed at 10-min intervals. Then, 1.2 mL of 20% cold
trichloroacetic acid was added and incubated for 10 min on ice;
this was followed by centrifugation at 3,000 rpm for 15 min to
collect the protein pellets. The pellets were washed three times
with 2.5 mL of ethanol/ethyl acetate (1:1, v/v) each to remove
non-reacted DNPH. The washed pellets containing 2,4-dinitro-
phenylhydrazone were resuspended in 6 M guanidine hydrochlo-
ride/0.5 M potassium phosphate monobasic, pH 2.5, at 37uC for
15 min with vortexing. The absorbance at 375 nm was measured
using the corresponding reagent blank for a zero setting. The
extinction coefficient for the 2,4-dinitrophenylhydrazone at
375 nm is 22,000 M
21 cm
21 and the protein carbonyl concen-
tration (nMol/mL) was calculated as the absorbance x 45.45 [29].
The content of protein carbonyl in the plasma was expressed per
mg of total proteins (measured by the dye-binding method). The
CV for determination of plasma protein carbonyl content was
8.43% (range: 2.72–13.80%).
Statistical analysis
The data with normal distribution were presented as the mean
6 standard deviation, and the data with skewed distribution were
presented as median (interquartile range, IQR). For comparisons
between two independent groups, the independent sample t-test
was used for normally distributed data, and the Mann-Whitney
test was used for skewed data. Pearson’s correlation test was used
to assess the correlation between continuous variables. A receiver
operating characteristic (ROC) analysis was performed to test the
ability of the COBRA LINE-1 methylation test to differentiate
BCa subjects from healthy subjects. An area under the ROC curve
(AUC) of 1.0 indicates perfect accuracy, whereas an AUC of 0.5
indicates that the test lacks discriminatory power. A cutoff value
was selected for computing the diagnostic values. SPSS version
17.0 (SSPS Inc., Chicago, IL) and STATA version 8.0 (StataCorp,
College Station, Texas) were used for all calculations. A P
value,0.05 was considered statistically significant.
Results
The BCa patients (n=61) were between 42 and 89 years of age
(65.11612.16 years) and consisted of 52 (85.25%) males and 9
(14.75%) females. In the control group, there were 45 healthy
subjects between 46 and 81 years of age (61.00613.25 years); this
group had 37 (82.22%) males and 8 (17.78%) females. Mean body
mass index (BMI) of the patient and control groups were
22.2463.71 and 23.1562.45 (kg/m
2), respectively. The sex
distribution, age and BMI between the two groups were not
significantly different.
The methylation level of LINE-1 was measured in DNA derived
from peripheral blood, urinary exfoliated cells and cancerous
tissues. The percentage of LINE-1 methylation in the peripheral
blood cells from the BCa patients was significantly lower than that
of the healthy controls (P=0.001) (Fig. 2A). Likewise, the LINE-1
methylation levels in the urinary exfoliated cells from the BCa
patients were significantly lower than those of the healthy controls
(P=0.044) (Fig. 2B). The LINE-1 methylation levels in the BCa
cancerous tissues were significantly lower than those in the urinary
exfoliated cells of the BCa (P=0.038) and healthy (P=0.001)
subjects (Fig. 2B). The percentage of
uC
uC loci in the peripheral
blood cells and urinary exfoliated cells of the BCa patients was
significantly greater than the controls (P=0.013 and ,0.001,
respectively) (Fig. 2C and 2D). The number of
mC
uC loci from the
urinary exfoliated cells of the BCa patients was significantly lower
than that of the controls (P=0.006), but the levels of
mC
uC loci in
the peripheral blood cells from the BCa and healthy groups were
not different (P=0.133) (Figure S1). These data confirmed the
presence of LINE-1 hypomethylation in bladder cancer and
showed similar results to those previously reported for oral cancer
[26] that demonstrated the specificity of
uC
uC loci to cancer DNA.
The determinations of the urinary TAS and plasma protein
carbonyl content were performed in both healthy and BCa groups.
A significant reduction in the urinary TAS level in the BCA
patients relative to the healthy controls was observed (P,0.001)
(Fig. 3A). The plasma protein carbonyl content in the BCa patients
was significantly higher than that in healthy controls (P,0.001)
(Fig. 3B). Our findings indicated an increase in the oxidative stress
in the BCa patients.
In the BCa patients, we found a strong, positive and linear
correlation between the urinary TAS and LINE-1 methylation in
circulating blood cells (regression coefficient=8.017) (r=0.618,
P,0.001) (Fig. 4A). Moreover, a significant positive correlation
between the urinary TAS and cancerous tissue LINE-1 methyl-
ation levels was observed (regression coefficient=5.519) (r=0.567,
P=0.034) (Fig. 4B). Interestingly, we also found a positive
correlation between the urinary TAS and the level of LINE-1
methylation in the peripheral blood cells of the healthy individuals
(regression coefficient=8.937) (r=0.469, P=0.001) (Fig. 4C). The
correlations between urinary TAS and the other patterns of LINE-
1 methylation (
mC
mC,
uC
uC,
uC
mC and
mC
uC) were evaluated
(Figure S2). The significant inverse correlations between urinary
TAS and the
uC
uC levels in BCa peripheral blood cells
(r=20.440, P=0.001), BCa cancerous tissues (r=20.440,
P=0.001) and peripheral blood cells of healthy controls
(r=20.315, P=0.035) were observed.
Using one-way ANOVA test, significant differences of LINE-1
methylation levels in blood, urine and cancerous tissue DNAs were
not observed among BCa patients with different smoking status
(non-smokers, current smokers and quitted smokers) (P=0.477,
0.711 and 0.964, respectively). Likewise, levels of urinary TAS and
plasma protein carbonyl content among the different smoking
status were not significantly different (P=0.053 and 0.093,
respectively). Urinary TAS (P=0.055 for healthy, P=0.879 for
BCa) and plasma protein carbonyl content (P=0.634 for healthy,
P=0.072 for BCa) were not significantly different between males
and females both in healthy and BCa groups. However, positive
correlation between urinary TAS and age in healthy group
(r=0.374, P=0.011) and negative correlation between plasma
protein carbonyl content and BMI in BCa group (r=20.261,
P=0.044) were revealed.
A ROC analysis was performed to evaluate how well the
determination of the LINE-1 methylation can discriminate
between the BCa patients and healthy individuals. Among the
various patterns of LINE-1 methylation, the
uC
uC level in the
urinary exfoliated cells had the greatest diagnostic value with the
highest AUC at 0.848 (95% CI: 0.719–0.977) (Table 1 and
Fig. 5A). At a 38.43% cutoff, sensitivity, specificity and accuracy of
the urinary
uC
uC determination were 80.00%, 85.00% and
LINE-1 and Oxidative Stress in Bladder Cancer
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both the blood (0.684) and the urine (0.691) cells were lower than
that of urinary
uC
uC (Figure S3). Thus, the determination of
uC
uC
in the urinary exfoliated cells provided the highest diagnostic
potential relative to the other forms of methylation.
The ROC curves of the urinary TAS and plasma protein
carbonyl content were also generated. The urinary TAS had an
AUC of 0.800 (95% CI: 0.711–0.888) and had sensitivity,
specificity and accuracy of 88.52%, 60.00%, and 76.42%,
respectively, at a cutoff of 1.32 VCEAC mM (Table 1 and
Fig. 5B). An AUC value for the plasma protein carbonyl content
was 0.819 (95% CI: 0.733–0.905), and its sensitivity, specificity
and accuracy, at a cutoff of 0.44 nMol/mg of protein, were
81.97%, 73.33% and 78.30%, respectively (Table 1 and Fig. 5C).
We further evaluated whether the combination of
uC
uC in the
urinary exfoliated cells and the plasma protein carbonyl content
Figure 2. The LINE-1 methylation and
uC
uC levels compared between the BCa and healthy groups. A: The percentage of LINE-1
methylation levels in the peripheral blood DNA from BCa patients (n=61) was significantly lower than that from the healthy controls (n=45). B: The
LINE-1 methylation levels in the DNA derived from the urinary exfoliated cells from BCa patients (n=30) were significantly decreased relative to those
from the healthy controls (n=14). The LINE-1 methylation levels in the cancerous tissues (n=14) were significantly lower than the LINE-1 methylation
levels in the urinary exfoliated cells from both BCa and healthy subjects. C: The
uC
uC levels in the peripheral blood DNA from BCa patients were
significantly higher than those from the healthy controls. D: The
uC
uC levels in the urinary exfoliated cells of BCa patients were significantly increased
compared to those from the healthy controls. The cancerous tissue
uC
uC levels were not significantly different from the
uC
uC levels from the BCa
urinary exfoliated cells (P=0.721), but they were significantly higher than those from the urinary exfoliated cells of healthy controls.
doi:10.1371/journal.pone.0037009.g002
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revealed that two positive results showed a higher specificity
(96.00% with sensitivity of 65.58%) and a higher sensitivity
(96.39% with specificity of 62.33%) when at least one marker was
positive (Fig. 6).
Discussion
The loss of DNA methylation in the LINE-1 elements is
suggested to be a cardinal event in cancer development because it
promotes genomic instability and alters gene expression [12–16].
The mechanism that causes this loss of DNA methylation is
unknown. The evaluation of the correlation of LINE-1 methyl-
ation levels between several loci suggested that the LINE-1
hypomethylation mechanism is generalized [23]. The timing of
DNA methylation and bladder cancer is not yet clear. Rather, it
has been shown to be a biomarker in post-diagnostic sample
analyses, however, this relationship has not been shown in using
pre-diagnostic samples, and it is not yet clear whether the lower
methylation observed was caused by the carcinogenic process itself
[30]. In the present study, we demonstrated here for the first time
a significant positive correlation between LINE-1 hypomethylation
and oxidative stress not only in cancer patients but also in healthy
individuals. Therefore, oxidative stress may be one of the causes or
consequences of LINE-1 hypomethylation.
Currently, to our knowledge, there is no biochemical mecha-
nism that implies how LINE-1 hypomethylation can produce
ROS. However, the mechanism of how oxidative stress reduces
Figure 3. The oxidative stress biomarkers in patients with BCa. A: The level of urinary TAS in the BCa patients was significantly lower than
that in the healthy controls. B: The level of the plasma protein carbonyl content in the BCa patients was significantly greater than that from the
healthy controls.
doi:10.1371/journal.pone.0037009.g003
Figure 4. A univariate correlation analysis between the levels of urinary TAS and LINE-1 methylation. A: The urinary TAS was linearly
correlated with the LINE-1 methylation levels in the peripheral blood cells of the BCa patients. B: The urinary TAS was linearly correlated with the LINE-
1 methylation levels in the cancerous tissue obtained from the BCa patients. C: In the healthy group, the urinary TAS was also linearly correlated with
the LINE-1 methylation levels in the peripheral blood cells. b: regression coefficient, r: Pearson’s correlation coefficient. The displayed P values are
from the Pearson’s correlation test.
doi:10.1371/journal.pone.0037009.g004
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stress-induced DNA methylation change appears to be temporal
[32,33]. Oxidized DNA lesions that are induced by ROS, such as
8-OHdG (in CpG dinucleotides), can strongly inhibit the
methylation by a DNA methyltransferase at the adjacent C
residues [34]. Additionally, an unfixed 8-OHdG may introduce
a G-T transversion resulting in the loss of CpG dinucleotides [35].
Additionally, in an oxidative stress condition, the resynthesis of
glutathione (GSH) in response to GSH depletion through the
methionine cycle in one-carbon metabolism pathway is increased.
This pathway requires S-adenosylmethionine (SAM) for synthe-
sizing the homocysteine to be used for the GSH synthesis, leading
to a decreased availability of SAM for DNA methylation [36]. The
agents and conditions that induce GSH depletion have been
demonstrated to impair DNA methylation [37,38]. Therefore,
oxidative stress is thought to alter the methylation of DNA, which
leads to changes in the gene expression that could contribute to
tumor development [7]. In addition to decreased availability of
SAM, depletion of methyl pool in folate-deficient models has been
shown to cause DNA hypomethylation [39,40].
The LINE-1 methylation levels have been studied in several
sources of DNA to improve cancer diagnosis. Unfortunately, there
are tissue specific methylation levels and that these differ
depending upon the methylation biomarker used to measure
methylation [15]. In clinical specimens both cancerous and
normal cells are usually coexisted, which means that based only
on the LINE-1 methylation levels cancer DNA cannot be
effectively detected when the DNA sources are contaminated
with DNA from various types of normal cells. For detection of
noninvasive BCa by DNA examination, blood and urine are the
common sources of DNA. Although cancer cells are present in
both sources, the contamination with various types of normal cells
is usually inevitable. Previously, we tested the DNA from both an
oral rinse and from the white blood cells of patients with oral
cancer and found that the percentage of hypomethylated loci or
uC
uC was more specific to the cancer DNA than the overall LINE-
1 methylation levels [26,41]. Moreover, the LINE-1 methylation
levels between the cell types (oral epithelial and blood cells) were
different because of the number of partial LINE-1 methylation
loci. Here, we showed similar data in BCa; the number of LINE-1
hypomethylated loci in urinary exfoliated cells is a better tumor
marker than the overall LINE-1 methylation level.
The increase in oxidative stress in BCa is well recognized and is
believed to be critically involved in urothelial carcinogenesis [3–6].
The study results support this association; there still need to be
experiments or analyses conducted using pre-diagnostic samples to
confirm the temporality of the association observed here. The
plasma protein carbonyl content was increased in the patients with
BCa relative to the levels in the healthy controls [42]. The total
antioxidant activity measured in the plasma of urothelial bladder
carcinoma patients was lower than that in healthy controls [43]. In
this study, we used the urinary TAS to reflect the overall
antioxidant capacity in the body because the urinary TAS is a well-
accepted marker for estimating the total antioxidants in biological
Figure 5. The ROC curves of
uC
uC determination, the urinary TAS and the plasma protein carbonyl content. A: The %
uC
uC in the
urinary exfoliated cells. B: The urinary TAS. C: The plasma protein carbonyl content. The determination of
uC
uC in the urinary exfoliated cells had the
highest AUC, which suggests the highest diagnostic potential.
doi:10.1371/journal.pone.0037009.g005
Table 1. The ROC analysis and diagnostic values of the measurements of the LINE-1 methylation and
uC
uC levels as well as
oxidative stress biomarkers.
Samples Measurements AUC Cutoff Sensitivity (%) Specificity (%) Accuracy (%)
Peripheral blood cells Methylation (%) 0.684 42.87 96.67 40.00 72.38
uC
uC (%) 0.641 34.64 50.00 77.78 61.90
Urinary exfoliated cells Methylation (%) 0.691 42.15 100.00 21.43 75.00
uC
uC (%) 0.848 38.43 80.00 85.00 81.82
Urine TAS (VCEAC mM) 0.800 1.32 88.52 60.00 76.42
Plasma Protein carbonyl 0.820 0.44 81.97 73.33 78.30
(nMol/mg proteins)
doi:10.1371/journal.pone.0037009.t001
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with BCa had an increase in oxidative stress. When combined with
the LINE-1 hypomethylation levels, we hypothesize that the
deprivation of antioxidants or an increase in oxidative stress may
influence the global hypomethylation that promotes carcinogen-
esis.
The ROC analysis revealed the promising diagnostic potential
of the measurements for the plasma protein carbonyl content and
the LINE-1 hypomethylated loci in urinary exfoliated cells. The
combination of these two tests increased the sensitivity and
specificity of the diagnostic values to 96%. This association needs
to be evaluated in pre-diagnostic samples. To date, there is no
biomarker that can replace the need for cystoscopy, and the
discovery of a new BCa biomarker is still a challenge for the field
[45]. Although many urinary biomarkers have been reported to
detect BCa with high sensitivity, their specificity is much lower
than the urine cytology (95–100%) [45,46]. A meta-analysis
reported that the sensitivity of urine cytology is only 34% [47].
Thus, a novel, noninvasive test with a high sensitivity and
specificity that is comparable to that of urine cytology is required.
Relative to the previously reported biomarkers for detecting BCa
[45–48], the current combination tests have shown to have
a diagnostic potential in the pre-diagnostic samples.
In conclusion, we found a positive correlation between the
LINE-1 hypomethylation of urine exfoliative cells and the
oxidative stress in both normal individuals and BCa patients.
ROS is hypothesized to be one of the candidate mechanisms that
can reduce LINE-1 methylation. Moreover, the ROS generation
and LINE-1 methylation levels and patterns in the blood, urinary
exfoliated cells and cancer cells from patients were significantly
changed relative to healthy controls. The combined information
from these two tests demonstrated a very high sensitivity and
specificity for BCa diagnosis, however, it needs to be confirmed
using pre-diagnostic samples, prior to implementation in cancer
diagnosis. Further studies of global hypomethylation and ROS will
not only improve our knowledge of carcinogenic mechanisms but
will also improve our management of the disease.
Statement of translational relevance
Patients with bladder cancer have increased oxidative stress and
LINE-1 hypomethylation relative to healthy controls. LINE-1
hypomethylation is correlated with an increased ROS generation
in both normal and cancer subjects, indicating a reverse associ-
ation between LINE1 methylation and oxidative stress. LINE-1
hypomethylation is known to promote genome instability, alter
gene expression and contribute to tumor progression. Thus, the
treatment that effectively reduces the oxidative stress in the
patients may attenuate the LINE-1 hypomethylation and de-
celerate the progression of the tumor. Until now, there has been
no noninvasive biomarker for detecting a bladder tumor that can
replace the need for cystoscopy. Based on pre-diagnostic samples,
the determination of the hypomethylated loci of LINE-1 in urinary
exfoliated cells combined with the plasma protein carbonyl
content show high sensitivity and specificity for bladder cancer
prediction. This combination test may be clinically useful for
bladder cancer diagnosis and monitoring of treatment thus
reducing the frequency of invasive cystoscopic procedures.
However, the test should be performed in pre-diagnostic samples
before the actual diagnostic power of the test can be evaluated.
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